CoreBev Announces Opening of New Flagship Distillery, Connecticut Distilling
"Connecticut Distilling is the culmination of years of hard work and dedication," says CoreBev founder and CEO
Connecticut Distilling uses a state-of-the-art process to create its unique spirits. The team, led by master distiller
Connecticut Distilling's distillery manager, Dimitrios Zahariadis, who was born in
The opening of Connecticut Distilling marks a new chapter for CoreBev and a bright future for the local community. "Putting our distillery here in
Connecticut Distilling is launching with five new products: "Charred" – Whiskey made from beer, "Drops" – a clear floral spirit made from beer, "Fort Hill" Bourbon, "Waterville" Vodka, and a Blueberry Rum, which is made by resting hand-picked
About CoreBev
CoreBev is committed to crafting exceptional spirits that embody innovation, sustainability, and tradition. With a portfolio of award-winning brands, CoreBev continues to redefine the industry standards, offering a unique and unparalleled drinking experience.
About Connecticut Distilling
Connecticut Distilling uses a state-of-the-art process to create its unique spirits. Using beer from our brewery partners, we use a sustainable brewing process that allows us to repurpose ingredients like sugars, yeast, and flavorful components for distilling. Recreating these flavors from scratch would be costly, but utilizing these tasty compounds from brewing waste marries sustainability with innovation, resulting in something exceptional. That is tradition refined, craft reborn.
Chief Operating Officer
CoreBev
[email protected]
This release was issued through WebWire®. For more information, visit http://www.webwire.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/corebev-announces-opening-of-new-flagship-distillery-connecticut-distilling-302179471.html
SOURCE CoreBev
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- InfraRed Capital Partners and Rail Modal Group announce investment to drive next stage of growth
- NRG Therapeutics Announces the Appointment of Claus Sundgreen M.D. as Chief Medical Officer
- Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share